RNF144A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.805790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.052200E-02
Normal-vs-Stage2
2.251200E-01
Normal-vs-Stage3
2.303200E-01
Normal-vs-Stage4
4.887200E-01
Stage1-vs-Stage2
2.814600E-01
Stage1-vs-Stage3
4.538400E-01
Stage1-vs-Stage4
3.409400E-01
Stage2-vs-Stage3
8.762400E-01
Stage2-vs-Stage4
7.901000E-01
Stage3-vs-Stage4
7.889800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.987800E-01
Normal-vs-AfricanAmerican
7.113600E-02
Normal-vs-Asian
1.982370E-02
Caucasian-vs-AfricanAmerican
7.859200E-01
Caucasian-vs-Asian
1.521430E-01
AfricanAmerican-vs-Asian
3.583800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.582200E-01
Normal-vs-Female
9.496300E-02
Male-vs-Female
7.001400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.336100E-02
Normal-vs-Age(41-60Yrs)
1.682010E-01
Normal-vs-Age(61-80Yrs)
2.192800E-01
Normal-vs-Age(81-100Yrs)
6.832300E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.971000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.974000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.675000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.336800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.075190E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.108400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.223900E-03
Normal-vs-Daily Drinker
6.098900E-03
Normal-vs-Weekly Drinker
2.255400E-01
Normal-vs-Occasional Drinker
6.179600E-02
Normal-vs-Social Drinker
2.783400E-01
Non Drinker-vs-Daily Drinker
7.932000E-01
Non Drinker-vs-Weekly Drinker
1.142560E-01
Non Drinker-vs-Occasional Drinker
7.976600E-01
Non Drinker-vs-Social Drinker
9.551900E-02
Daily Drinker-vs-Weekly Drinker
9.407800E-02
Daily Drinker-vs-Occasional Drinker
6.577000E-01
Daily Drinker-vs-Social Drinker
8.273800E-02
Weekly Drinker-vs-Occasional Drinker
2.977000E-01
Weekly Drinker-vs-Social Drinker
9.293200E-01
Occasional Drinker-vs-Social Drinker
2.644000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.599200E-01
Normal-vs-Grade 2
7.214000E-01
Normal-vs-Grade 3
7.983600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.056000E-03
Grade 1-vs-Grade 3
3.703700E-02
Grade 1-vs-Grade 4
6.599200E-01
Grade 2-vs-Grade 3
5.568600E-01
Grade 2-vs-Grade 4
7.214000E-01
Grade 3-vs-Grade 4
7.983600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.546430E-01
Normal-vs-NonDiabetic
5.493600E-02
Diabetic-vs-NonDiabetic
5.263000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.766570E-01
Normal-vs-NoPancreatitis
8.248500E-02
Pancreatitis-vs-NoPancreatitis
9.307600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.461900E-02
Normal-vs-N1
2.816800E-01
N0-vs-N1
3.090400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.918200E-01
Normal-vs-TP53-NonMutant
1.175430E-01
TP53-Mutant-vs-TP53-NonMutant
4.036400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
